ZNF177 and colorectal carcinoma: In summary, our results demonstrate that the combination of the methylation statuses of NKX6.1, LMX1A, SOX1, and ZNF177 is a novel prognostic panel that could be considered a molecular marker for outcomes in CRC patients.